Karjalainen U - Search Results

1

Genetic susceptibility of intervertebral disc degeneration among young Finnish adults.

Kelempisioti A, Eskola PJ, Okuloff A, Karjalainen U, Takatalo J, Daavittila I, Niinimäki J, Sequeiros RB, Tervonen O, Solovieva S, Kao PY, Song YQ, Cheung KM, Chan D, Ala-Kokko L, Järvelin MR, Karppinen J, Männikkö M. Kelempisioti A, et al. Among authors: karjalainen u. BMC Med Genet. 2011 Nov 22;12:153. doi: 10.1186/1471-2350-12-153. BMC Med Genet. 2011. PMID: 22107760 Free PMC article.

2

Role of environmental factors and history of low back pain in sciatica symptoms among Finnish adolescents.

Karjalainen U, Paananen M, Okuloff A, Taimela S, Auvinen J, Männikkö M, Karppinen J. Karjalainen U, et al. Spine (Phila Pa 1976). 2013 Jun 1;38(13):1105-11. doi: 10.1097/BRS.0b013e318287fb3a. Spine (Phila Pa 1976). 2013. PMID: 23354107

3

Determination of dopamine and methoxycatecholamines in patient urine by liquid chromatography with electrochemical detection and by capillary electrophoresis coupled with spectrophotometry and mass spectrometry.

Vuorensola K, Sirén H, Karjalainen U. Vuorensola K, et al. Among authors: karjalainen u. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 May 25;788(2):277-89. doi: 10.1016/s1570-0232(02)01037-1. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12705968

4

Study of catecholamines in patient urine samples by capillary electrophoresis.

Sirén H, Karjalainen U. Sirén H, et al. Among authors: karjalainen u. J Chromatogr A. 1999 Aug 20;853(1-2):527-33. doi: 10.1016/s0021-9673(99)00679-2. J Chromatogr A. 1999. PMID: 10486762

5

Urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion during multiple-day high-dose chemotherapy.

Janes RJ, Muhonen T, Karjalainen UP, Wiklund T. Janes RJ, et al. Among authors: karjalainen up. Eur J Cancer. 1998 Jan;34(1):196-8. doi: 10.1016/s0959-8049(97)00322-5. Eur J Cancer. 1998. PMID: 9624258

6

Breath acetone in congestive heart failure.

Kupari M, Lommi J, Ventilä M, Karjalainen U. Kupari M, et al. Among authors: karjalainen u. Am J Cardiol. 1995 Nov 15;76(14):1076-8. doi: 10.1016/s0002-9149(99)80304-x. Am J Cardiol. 1995. PMID: 7484868

7

Two alpha-chain hemoglobin variants, Hb Broussais and Hb Cemenelum, characterized by cation-exchange HPLC, isoelectric focusing, and peptide sequencing.

Turpeinen U, Sipilä I, Anttila P, Karjalainen U, Kuronen B, Kalkkinen N, Ahola T, Stenman UH. Turpeinen U, et al. Among authors: karjalainen u. Clin Chem. 1995 Apr;41(4):532-6. Clin Chem. 1995. PMID: 7720241

8

Three assays for glycohemoglobin compared.

Turpeinen U, Karjalainen U, Stenman UH. Turpeinen U, et al. Among authors: karjalainen u. Clin Chem. 1995 Feb;41(2):191-5. Clin Chem. 1995. PMID: 7874770

9

Finding the "natural" vector bases for multidimensional reference values.

Karjalainen EJ, Karjalainen UP. Karjalainen EJ, et al. Among authors: karjalainen up. Scand J Clin Lab Invest Suppl. 1995;222:61-7. doi: 10.3109/00365519509088451. Scand J Clin Lab Invest Suppl. 1995. PMID: 7569747

10

The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.

Faulkner JK, Himanen P, Karjalainen U, Saraste M. Faulkner JK, et al. Among authors: karjalainen u. Eur J Clin Pharmacol. 1987;31(6):685-93. doi: 10.1007/BF00541296. Eur J Clin Pharmacol. 1987. PMID: 2951261 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page